Victory Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $240M | Buy |
621,258
+356,960
| +135% | +$132M | 0.13% | 171 |
|
|
2026
Q1 | $77.4M | Buy |
264,298
+136,518
| +107% | +$44.9M | 0.05% | 376 |
|
|
2025
Q4 | $44.8M | Sell |
127,780
-333,913
| -72% | -$113M | 0.03% | 587 |
|
|
2025
Q3 | $149M | Buy |
461,693
+109,462
| +31% | +$34M | 0.09% | 214 |
|
|
2025
Q2 | $137M | Buy |
352,231
+225,797
| +179% | +$90.8M | 0.09% | 236 |
|
|
2025
Q1 | $55M | Sell |
126,434
-124,855
| -50% | -$50.1M | 0.06% | 422 |
|
|
2024
Q4 | $92.7M | Buy |
251,289
+48,247
| +24% | +$20.2M | 0.09% | 249 |
|
|
2024
Q3 | $106M | Buy |
203,042
+8,851
| +5% | +$4.73M | 0.1% | 233 |
|
|
2024
Q2 | $105M | Buy |
194,191
+26,382
| +16% | +$13.9M | 0.11% | 225 |
|
|
2024
Q1 | $87M | Sell |
167,809
-19,597
| -10% | -$9.75M | 0.08% | 287 |
|
|
2023
Q4 | $88.4M | Buy |
187,406
+12,268
| +7% | +$5.67M | 0.09% | 276 |
|
|
2023
Q3 | $76.3M | Sell |
175,138
-2,642
| -1% | -$1.2M | 0.09% | 292 |
|
|
2023
Q2 | $79M | Sell |
177,780
-13,881
| -7% | -$6.4M | 0.09% | 289 |
|
|
2023
Q1 | $88.1M | Sell |
191,661
-51,908
| -21% | -$24.7M | 0.1% | 267 |
|
|
2022
Q4 | $125M | Buy |
243,569
+16,411
| +7% | +$8.33M | 0.14% | 164 |
|
|
2022
Q3 | $103M | Buy |
227,158
+15,070
| +7% | +$7.21M | 0.12% | 215 |
|
|
2022
Q2 | $102M | Buy |
212,088
+12,376
| +6% | +$6.12M | 0.12% | 224 |
|
|
2022
Q1 | $100M | Buy |
199,712
+21,881
| +12% | +$10M | 0.1% | 265 |
|
|
2021
Q4 | $82.4M | Sell |
177,831
-1,045
| -0.6% | -$440K | 0.08% | 359 |
|
|
2021
Q3 | $66.7M | Buy |
178,876
+44,324
| +33% | +$16.8M | 0.07% | 428 |
|
|
2021
Q2 | $51.4M | Sell |
134,552
-7,583
| -5% | -$2.9M | 0.05% | 557 |
|
|
2021
Q1 | $51M | Sell |
142,135
-24,893
| -15% | -$8.01M | 0.05% | 546 |
|
|
2020
Q4 | $53.6M | Sell |
167,028
-10,023
| -6% | -$3.08M | 0.06% | 500 |
|
|
2020
Q3 | $47.6M | Buy |
177,051
+6,945
| +4% | +$1.87M | 0.06% | 481 |
|
|
2020
Q2 | $44.7M | Buy |
170,106
+28,605
| +20% | +$7.63M | 0.06% | 461 |
|
|
2020
Q1 | $32.1M | Sell |
141,501
-73,903
| -34% | -$20.1M | 0.05% | 489 |
|
|
2019
Q4 | $65.1M | Buy |
215,404
+16,743
| +8% | +$4.61M | 0.08% | 373 |
|
|
2019
Q3 | $47.7M | Buy |
198,661
+136,884
| +222% | +$37.5M | 0.06% | 460 |
|
|
2019
Q2 | $17.4M | Sell |
61,777
-3,019
| -5% | -$825K | 0.04% | 649 |
|
|
2019
Q1 | $18.6M | Buy |
64,796
+44,685
| +222% | +$12.9M | 0.04% | 589 |
|
|
2018
Q4 | $5.28M | Sell |
20,111
-81
| -0.4% | -$22.3K | 0.01% | 814 |
|
|
2018
Q3 | $5.53M | Sell |
20,192
-48,893
| -71% | -$12.7M | 0.01% | 841 |
|
|
2018
Q2 | $16.4M | Buy |
69,085
+52,152
| +308% | +$12.1M | 0.04% | 649 |
|
|
2018
Q1 | $3.72M | Buy |
16,933
+350
| +2% | +$82.2K | 0.01% | 886 |
|
|
2017
Q4 | $3.73M | Buy |
16,583
+1,130
| +7% | +$241K | 0.01% | 870 |
|
|
2017
Q3 | $2.93M | Buy |
15,453
+1,718
| +13% | +$327K | 0.01% | 890 |
|
|
2017
Q2 | $2.58M | Buy |
13,735
+1,357
| +11% | +$244K | 0.01% | 895 |
|
|
2017
Q1 | $2.05M | Buy |
12,378
+370
| +3% | +$58.9K | ﹤0.01% | 919 |
|
|
2016
Q4 | $1.73M | Buy |
12,008
+722
| +6% | +$96.7K | ﹤0.01% | 947 |
|
|
2016
Q3 | $1.41M | Buy |
11,286
+2,821
| +33% | +$364K | ﹤0.01% | 934 |
|
|
2016
Q2 | $1.11M | Buy |
8,465
+203
| +2% | +$27.8K | ﹤0.01% | 760 |
|
|
2016
Q1 | $1.15M | Sell |
8,262
-274
| -3% | -$36.6K | ﹤0.01% | 752 |
|
|
2015
Q4 | $1.19M | Buy |
8,536
+1,838
| +27% | +$253K | ﹤0.01% | 741 |
|
|
2015
Q3 | $937K | Sell |
6,698
-147,448
| -96% | -$22.2M | ﹤0.01% | 734 |
|
|
2015
Q2 | $25.3M | Sell |
154,146
-110,688
| -42% | -$17.7M | 0.09% | 354 |
|
|
2015
Q1 | $40.9M | Sell |
264,834
-118,566
| -31% | -$16.9M | 0.15% | 238 |
|
|
2014
Q4 | $48.2M | Buy |
383,400
+105,000
| +38% | +$13M | 0.18% | 183 |
|
|
2014
Q3 | $33.3M | Buy |
+278,400
| New | +$31.9M | 0.25% | 143 |
|
|
2013
Q4 | – | Sell |
-86
| Closed | -$7K | – | 971 |
|
|
2013
Q3 | $7K | Buy |
+86
| New | +$7.37K | ﹤0.01% | 1078 |
|
Other funds holding ELV
Victory Capital Management's ELV Position: Q2 2026 in Review
Victory Capital Management increased its Elevance Health (ELV) stake by 135% in Q2 2026, buying an estimated $132M and bringing the position to 621,258 shares worth $240M. The position accounts for 0.13% of the portfolio, ranked #171.
Victory Capital Management first reported a position in ELV in Q3 2013 and has held it in 49 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Victory Capital Management held 621,258 shares of Elevance Health worth $240M as of Q2 2026.
- Victory Capital Management bought 356,960 Elevance Health shares in Q2 2026, an estimated $132M.
- Elevance Health made up 0.13% of Victory Capital Management's portfolio in Q2 2026, its #171 holding.
- Victory Capital Management first reported a position in Elevance Health in Q3 2013 and has held it in 49 quarters since.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.